+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Brain Mapping Instruments Market - Global Forecast 2026-2032- Product Image
Brain Mapping Instruments Market - Global Forecast 2026-2032- Product Image
Sale

Brain Mapping Instruments Market - Global Forecast 2026-2032

  • Report

  • 183 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6011109
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Brain Mapping Instruments Market is projected to reach USD 2.31 Billion in 2026. It is expected to continue growing at a CAGR of 14.33%, reaching USD 5.15 Billion by 2032.

Brain mapping instruments are becoming core infrastructure for neuroscience, neurology, psychiatry, neurosurgery, and brain-computer interface research. Demand is supported by the growing burden of neurological disease; the World Health Organization has reported that neurological conditions affect more than 3 billion people worldwide, while dementia, epilepsy, stroke, Parkinson’s disease, multiple sclerosis, migraine, and traumatic brain injury continue to increase the need for objective brain assessment.

The market spans MRI and functional MRI, EEG, MEG, PET, SPECT, optical imaging, near-infrared spectroscopy, neuronavigation, electrophysiology platforms, and integrated analytics software. For instrument manufacturers, competitive advantage is shifting toward higher spatial and temporal resolution, multimodal workflows, interoperability with hospital systems, and validated artificial intelligence that improves acquisition, reconstruction, segmentation, and clinical interpretation.

Transformative Shifts in the Brain Mapping Landscape

The landscape is moving from stand-alone imaging and electrophysiology devices toward connected, multimodal brain mapping ecosystems. Hospitals and research centers increasingly require systems that combine structural, functional, metabolic, and electrophysiological data to support epilepsy surgery planning, tumor margin assessment, neurodegenerative disease research, concussion evaluation, psychiatric biomarker discovery, and brain-computer interface development.

Procurement decisions are also changing. Buyers are placing more weight on total cost of ownership, regulatory clearance, cybersecurity, data portability, cloud compatibility, service uptime, and evidence that instruments improve workflow efficiency. Manufacturers that combine hardware excellence with software, service, and clinical evidence are better positioned than vendors competing only on device specifications.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is having a cumulative effect across the brain mapping instruments value chain. In imaging, AI supports faster MRI reconstruction, artifact reduction, automated segmentation, quantitative lesion analysis, image registration, and decision support. In EEG and MEG, machine learning helps detect epileptiform activity, classify sleep and cognitive states, remove noise, and support real-time signal interpretation.

The most commercially relevant AI applications are those that reduce scan time, improve reproducibility, and integrate into regulated clinical workflows. Instrument leaders must treat AI as a quality-controlled medical technology rather than a generic software feature, with attention to model validation, bias testing, explainability, post-market monitoring, cybersecurity, and compliance with FDA, EU MDR, and other medical device frameworks.

Key Regional Insights

Asia-Pacific is expanding rapidly as China, Japan, South Korea, India, Australia, and ASEAN countries invest in neuroscience research, advanced hospitals, and domestic medical technology capacity. The region’s demand is reinforced by aging populations in Japan, China, and South Korea, rising stroke and dementia burdens, and wider deployment of MRI, EEG, PET, and digital neurology systems in tertiary care. North America remains the leading commercialization hub because of NIH-backed neuroscience programs, strong university medical centers, FDA-cleared neuroimaging innovation, and a large installed base of MRI, PET, EEG, and neurosurgical navigation systems.

Latin America shows selective growth led by Brazil and Mexico, where private hospital networks and academic centers are adding advanced neurodiagnostic capacity despite currency and reimbursement constraints. Europe benefits from mature clinical neuroscience networks, Horizon Europe funding, and strong neurotechnology engineering, although EU MDR requirements raise the bar for evidence, post-market surveillance, and compliance.

The Middle East is building premium neurology and imaging capacity through government-backed hospital modernization, particularly in GCC markets focused on tertiary care, digital health, and medical tourism. Africa remains underpenetrated, but demand is rising for scalable EEG, portable imaging support, tele-neurology workflows, and cost-effective instruments that can operate in resource-constrained settings.

Key Group Insights

ASEAN demand is shaped by expanding private healthcare, medical tourism, and university-based neuroscience programs, with Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines showing different levels of readiness for advanced MRI, EEG, and digital neurology platforms. The GCC is driven by national health transformation plans, tertiary hospital investment, and demand for premium diagnostic and neurosurgical systems that support specialist neurology, stroke, epilepsy, and neurorehabilitation services.

The European Union is a high-value but compliance-intensive market where MDR conformity, data protection, sustainability expectations, and cross-border research consortia influence vendor selection. BRICS markets represent large patient pools and strategic localization opportunities, especially in China, India, and Brazil, while Russia faces technology access and geopolitical constraints that affect procurement, servicing, and component availability.

G7 countries anchor premium adoption because they combine advanced clinical infrastructure, reimbursement pathways, research grants, and high publication output in neuroscience. NATO member states also create demand through traumatic brain injury research, neuroperformance monitoring, rehabilitation, and defense-related brain health programs, particularly where military medicine intersects with neuroimaging, electrophysiology, and cognitive assessment.

Key Country Insights

The United States leads adoption through strong NIH funding, academic medical centers, FDA-regulated innovation, and a robust installed base for MRI, PET, EEG, MEG, and neurosurgical navigation. Canada benefits from publicly funded neuroscience networks and strong imaging research, while Mexico is growing through private hospital investment, medical tourism, and cross-border clinical demand. Brazil is Latin America’s largest opportunity, supported by tertiary care expansion, academic neurology centers, and rising demand for epilepsy, stroke, and dementia assessment.

The United Kingdom, Germany, France, Italy, and Spain remain important European markets due to established hospital systems, specialist neurology services, and research capabilities; Germany is especially strong in engineering and precision instrumentation, while the United Kingdom and France have prominent neuroscience consortia and advanced imaging programs. Russia retains scientific expertise in neurophysiology and imaging but faces procurement friction linked to sanctions, supply chain limitations, and restricted access to advanced components.

China is scaling domestic production, AI imaging, hospital modernization, and neuroscience research at speed. India is a high-growth market for affordable EEG, wider MRI access, digital neurology, and telemedicine-enabled brain health services, while Japan and South Korea emphasize advanced imaging, aging-related disease research, precision healthcare, and robotics-enabled clinical workflows. Australia contributes strong clinical research, neuroimaging networks, and demand for high-quality imported systems across public and private care settings.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize multimodal compatibility, AI-enabled workflow gains, and service models that reduce downtime for hospitals and research centers. Product roadmaps should emphasize validated algorithms, automated quality control, portable and scalable platforms, and connectivity with PACS, EHR, cloud, and research data repositories.

Commercial teams should localize pricing, training, and regulatory strategies by region. Manufacturers can strengthen adoption by partnering with academic medical centers, neurosurgery programs, epilepsy centers, dementia clinics, rehabilitation providers, and pharmaceutical sponsors that need biomarker-grade brain mapping for clinical trials.

Research Methodology

This executive summary is grounded in secondary research from public health agencies, regulatory bodies, scientific literature, clinical trial activity, public procurement patterns, neuroscience funding programs, and technology adoption trends. Key sources considered include WHO neurological disease references, NIH and BRAIN Initiative materials, FDA medical device guidance, EU MDR requirements, and peer-reviewed neuroimaging and electrophysiology research.

The analysis triangulates disease burden, technology adoption, regional healthcare investment, regulatory trends, and end-user purchasing behavior. Insights are structured for strategic decision-making across manufacturers, distributors, healthcare providers, research institutions, and investors in the brain mapping instruments market, without relying on market sizing, market share, or forecasting.

Conclusion

Brain mapping instruments are advancing from specialized research tools into essential clinical and translational platforms. The strongest opportunities are emerging where high-quality hardware, AI-enabled analytics, regulatory compliance, and interoperable data workflows converge.

Manufacturers that invest in clinical evidence, regional localization, cybersecurity, and scalable service infrastructure will be best positioned to address demand. As neurological disease burden rises and precision neuroscience gains momentum, brain mapping instruments will remain central to diagnosis, therapy planning, research, rehabilitation, and next-generation neurotechnology.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Brain Mapping Instruments Market, by Component
7.1. Introduction
7.2. Hardware
7.2.1. Analysis Equipment
7.2.2. Electrodes & Sensors
7.2.3. Scanners
7.3. Services
7.3.1. Consulting
7.3.2. Maintenance & Training
7.4. Software
7.4.1. Analysis Software
7.4.2. Data Management Software
8. Brain Mapping Instruments Market, by Technology
8.1. Introduction
8.2. EEG
8.2.1. Portable EEG Systems
8.2.2. Stationary EEG Systems
8.2.3. Wireless EEG Systems
8.3. fMRI
8.3.1. Clinical fMRI
8.3.2. Research fMRI
8.4. MEG
8.4.1. Helmet-Based MEG
8.4.2. Wearable MEG
8.5. NIRS
8.5.1. Continuous Wave NIRS
8.5.2. Frequency Domain NIRS
8.5.3. Time Domain NIRS
8.6. PET
8.6.1. Amyloid PET
8.6.2. FDG-PET
8.6.3. Tau PET
9. Brain Mapping Instruments Market, by Modality
9.1. Introduction
9.2. Functional Imaging
9.3. Structural Imaging
9.4. Connectivity Mapping
9.5. Neurochemical Mapping
10. Brain Mapping Instruments Market, by Application
10.1. Introduction
10.2. Clinical
10.2.1. Neurology
10.2.2. Oncology
10.2.3. Psychiatry
10.3. Research
10.3.1. Academic Research
10.3.2. Cognitive Neuroscience
10.3.3. Pharmaceutical Research
11. Brain Mapping Instruments Market, by End User
11.1. Introduction
11.2. Academic & Research Institutes
11.3. Hospitals & Diagnostic Centers
11.4. Pharmaceutical & Biotechnology Companies
12. Brain Mapping Instruments Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Brain Mapping Instruments Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Brain Mapping Instruments Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Advanced Brain Monitoring, Inc.
16.3. ANT Neuro B.V.
16.4. Boston Scientific Corporation
16.5. Brain Products GmbH
16.6. Cadwell Industries, Inc.
16.7. CGX, A Cognionics Company
16.8. Compumedics Limited
16.9. Deymed Diagnostic
16.10. Elekta AB
16.11. General Electric Company
16.12. Koninklijke Philips N.V.
16.13. Magstim Company Limited
16.14. Medtronic plc
16.15. MEGIN Oy
16.16. Mrisym AG
16.17. Natus Medical Incorporated
16.18. Neuroelectrics Barcelona SL
16.19. Neurosoft LLC
16.20. NeuroWave Systems Inc.
16.21. Nihon Kohden Corporation
16.22. Rogue Research Inc.
16.23. Siemens Healthineers AG
16.24. York Instruments Ltd.
17. Key Experts
List of Figures
FIGURE 1. Global Brain Mapping Instruments Market, Years Considered for the Study
FIGURE 2. Global Brain Mapping Instruments Market, Research Design
FIGURE 3. Global Brain Mapping Instruments Market, Research Framework
FIGURE 4. Global Brain Mapping Instruments Market, Data Triangulation
FIGURE 5. Global Brain Mapping Instruments Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Brain Mapping Instruments Market Size, by Component, 2025 vs 2032 (%)
FIGURE 7. Global Brain Mapping Instruments Market Size, by Component, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Brain Mapping Instruments Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Brain Mapping Instruments Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Brain Mapping Instruments Market Size, by Modality, 2025 vs 2032 (%)
FIGURE 11. Global Brain Mapping Instruments Market Size, by Modality, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Brain Mapping Instruments Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Brain Mapping Instruments Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Brain Mapping Instruments Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Brain Mapping Instruments Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Brain Mapping Instruments Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Brain Mapping Instruments Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Brain Mapping Instruments Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Brain Mapping Instruments Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Brain Mapping Instruments Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Brain Mapping Instruments Market Share, by Key Player, 2025
List of Tables
TABLE 1. Global Brain Mapping Instruments Market Segmentation & Coverage
TABLE 2. Global Brain Mapping Instruments Market Size, 2017-2032 (USD Million)
TABLE 3. Global Brain Mapping Instruments Market Size, by Component, 2017-2032 (USD Million)
TABLE 4. Global Hardware Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Hardware Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Hardware Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Analysis Equipment Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Analysis Equipment Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Analysis Equipment Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Electrodes & Sensors Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Electrodes & Sensors Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Electrodes & Sensors Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Scanners Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Scanners Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Scanners Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Consulting Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Consulting Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Consulting Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Maintenance & Training Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Maintenance & Training Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Maintenance & Training Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Analysis Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Analysis Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Analysis Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Data Management Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Data Management Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Data Management Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Brain Mapping Instruments Market Size, by Technology, 2017-2032 (USD Million)
TABLE 35. Global EEG Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global EEG Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global EEG Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Portable EEG Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Portable EEG Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Portable EEG Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Stationary EEG Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Stationary EEG Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Stationary EEG Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Wireless EEG Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Wireless EEG Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Wireless EEG Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global fMRI Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global fMRI Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global fMRI Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Clinical fMRI Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Clinical fMRI Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Clinical fMRI Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Research fMRI Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Research fMRI Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Research fMRI Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global MEG Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global MEG Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global MEG Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Helmet-Based MEG Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Helmet-Based MEG Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Helmet-Based MEG Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Wearable MEG Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Wearable MEG Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Wearable MEG Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global NIRS Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global NIRS Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global NIRS Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Continuous Wave NIRS Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Continuous Wave NIRS Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Continuous Wave NIRS Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Frequency Domain NIRS Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Frequency Domain NIRS Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Frequency Domain NIRS Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Time Domain NIRS Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Time Domain NIRS Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Time Domain NIRS Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global PET Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global PET Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global PET Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Amyloid PET Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Amyloid PET Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Amyloid PET Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global FDG-PET Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global FDG-PET Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global FDG-PET Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Tau PET Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Tau PET Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Tau PET Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Brain Mapping Instruments Market Size, by Modality, 2017-2032 (USD Million)
TABLE 90. Global Functional Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Functional Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Functional Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Structural Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Structural Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Structural Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Connectivity Mapping Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global Connectivity Mapping Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global Connectivity Mapping Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global Neurochemical Mapping Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Global Neurochemical Mapping Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. Global Neurochemical Mapping Market Size, by Country, 2017-2032 (USD Million)
TABLE 102. Global Brain Mapping Instruments Market Size, by Application, 2017-2032 (USD Million)
TABLE 103. Global Clinical Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Clinical Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Clinical Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Neurology Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Neurology Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Neurology Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Psychiatry Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Psychiatry Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Psychiatry Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Academic Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Global Academic Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. Global Academic Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 121. Global Cognitive Neuroscience Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Global Cognitive Neuroscience Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. Global Cognitive Neuroscience Market Size, by Country, 2017-2032 (USD Million)
TABLE 124. Global Pharmaceutical Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 125. Global Pharmaceutical Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. Global Pharmaceutical Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 127. Global Brain Mapping Instruments Market Size, by End User, 2017-2032 (USD Million)
TABLE 128. Global Academic & Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Global Academic & Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. Global Academic & Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 131. Global Hospitals & Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 132. Global Hospitals & Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. Global Hospitals & Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 134. Global Pharmaceutical & Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. Global Pharmaceutical & Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. Global Pharmaceutical & Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 137. Global Brain Mapping Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 138. Asia-Pacific Brain Mapping Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 139. Asia-Pacific Brain Mapping Instruments Market Size, by Component, 2017-2032 (USD Million)
TABLE 140. Asia-Pacific Brain Mapping Instruments Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 141. Asia-Pacific Brain Mapping Instruments Market Size, by Services, 2017-2032 (USD Million)
TABLE 142. Asia-Pacific Brain Mapping Instruments Market Size, by Software, 2017-2032 (USD Million)
TABLE 143. Asia-Pacific Brain Mapping Instruments Market Size, by Technology, 2017-2032 (USD Million)
TABLE 144. Asia-Pacific Brain Mapping Instruments Market Size, by EEG, 2017-2032 (USD Million)
TABLE 145. Asia-Pacific Brain Mapping Instruments Market Size, by fMRI, 2017-2032 (USD Million)
TABLE 146. Asia-Pacific Brain Mapping Instruments Market Size, by MEG, 2017-2032 (USD Million)
TABLE 147. Asia-Pacific Brain Mapping Instruments Market Size, by NIRS, 2017-2032 (USD Million)
TABLE 148. Asia-Pacific Brain Mapping Instruments Market Size, by PET, 2017-2032 (USD Million)
TABLE 149. Asia-Pacific Brain Mapping Instruments Market Size, by Modality, 2017-2032 (USD Million)
TABLE 150. Asia-Pacific Brain Mapping Instruments Market Size, by Application, 2017-2032 (USD Million)
TABLE 151. Asia-Pacific Brain Mapping Instruments Market Size, by Clinical, 2017-2032 (USD Million)
TABLE 152. Asia-Pacific Brain Mapping Instruments Market Size, by Research, 2017-2032 (USD Million)
TABLE 153. Asia-Pacific Brain Mapping Instruments Market Size, by End User, 2017-2032 (USD Million)
TABLE 154. North America Brain Mapping Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 155. North America Brain Mapping Instruments Market Size, by Component, 2017-2032 (USD Million)
TABLE 156. North America Brain Mapping Instruments Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 157. North America Brain Mapping Instruments Market Size, by Services, 2017-2032 (USD Million)
TABLE 158. North America Brain Mapping Instruments Market Size, by Software, 2017-2032 (USD Million)
TABLE 159. North America Brain Mapping Instruments Market Size, by Technology, 2017-2032 (USD Million)
TABLE 160. North America Brain Mapping Instruments Market Size, by EEG, 2017-2032 (USD Million)
TABLE 161. North America Brain Mapping Instruments Market Size, by fMRI, 2017-2032 (USD Million)
TABLE 162. North America Brain Mapping Instruments Market Size, by MEG, 2017-2032 (USD Million)
TABLE 163. North America Brain Mapping Instruments Market Size, by NIRS, 2017-2032 (USD Million)
TABLE 164. North America Brain Mapping Instruments Market Size, by PET, 2017-2032 (USD Million)
TABLE 165. North America Brain Mapping Instruments Market Size, by Modality, 2017-2032 (USD Million)
TABLE 166. North America Brain Mapping Instruments Market Size, by Application, 2017-2032 (USD Million)
TABLE 167. North America Brain Mapping Instruments Market Size, by Clinical, 2017-2032 (USD Million)
TABLE 168. North America Brain Mapping Instruments Market Size, by Research, 2017-2032 (USD Million)
TABLE 169. North America Brain Mapping Instruments Market Size, by End User, 2017-2032 (USD Million)
TABLE 170. Latin America Brain Mapping Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 171. Latin America Brain Mapping Instruments Market Size, by Component, 2017-2032 (USD Million)
TABLE 172. Latin America Brain Mapping Instruments Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 173. Latin America Brain Mapping Instruments Market Size, by Services, 2017-2032 (USD Million)
TABLE 174. Latin America Brain Mapping Instruments Market Size, by Software, 2017-2032 (USD Million)
TABLE 175. Latin America Brain Mapping Instruments Market Size, by Technology, 2017-2032 (USD Million)
TABLE 176. Latin America Brain Mapping Instruments Market Size, by EEG, 2017-2032 (USD Million)
TABLE 177. Latin America Brain Mapping Instruments Market Size, by fMRI, 2017-2032 (USD Million)
TABLE 178. Latin America Brain Mapping Instruments Market Size, by MEG, 2017-2032 (USD Million)
TABLE 179. Latin America Brain Mapping Instruments Market Size, by NIRS, 2017-2032 (USD Million)
TABLE 180. Latin America Brain Mapping Instruments Market Size, by PET, 2017-2032 (USD Million)
TABLE 181. Latin America Brain Mapping Instruments Market Size, by Modality, 2017-2032 (USD Million)
TABLE 182. Latin America Brain Mapping Instruments Market Size, by Application, 2017-2032 (USD Million)
TABLE 183. Latin America Brain Mapping Instruments Market Size, by Clinical, 2017-2032 (USD Million)
TABLE 184. Latin America Brain Mapping Instruments Market Size, by Research, 2017-2032 (USD Million)
TABLE 185. Latin America Brain Mapping Instruments Market Size, by End User, 2017-2032 (USD Million)
TABLE 186. Europe Brain Mapping Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 187. Europe Brain Mapping Instruments Market Size, by Component, 2017-2032 (USD Million)
TABLE 188. Europe Brain Mapping Instruments Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 189. Europe Brain Mapping Instruments Market Size, by Services, 2017-2032 (USD Million)
TABLE 190. Europe Brain Mapping Instruments Market Size, by Software, 2017-2032 (USD Million)
TABLE 191. Europe Brain Mapping Instruments Market Size, by Technology, 2017-2032 (USD Million)
TABLE 192. Europe Brain Mapping Instruments Market Size, by EEG, 2017-2032 (USD Million)
TABLE 193. Europe Brain Mapping Instruments Market Size, by fMRI, 2017-2032 (USD Million)
TABLE 194. Europe Brain Mapping Instruments Market Size, by MEG, 2017-2032 (USD Million)
TABLE 195. Europe Brain Mapping Instruments Market Size, by NIRS, 2017-2032 (USD Million)
TABLE 196. Europe Brain Mapping Instruments Market Size, by PET, 2017-2032 (USD Million)
TABLE 197. Europe Brain Mapping Instruments Market Size, by Modality, 2017-2032 (USD Million)
TABLE 198. Europe Brain Mapping Instruments Market Size, by Application, 2017-2032 (USD Million)
TABLE 199. Europe Brain Mapping Instruments Market Size, by Clinical, 2017-2032 (USD Million)
TABLE 200. Europe Brain Mapping Instruments Market Size, by Research, 2017-2032 (USD Million)
TABLE 201. Europe Brain Mapping Instruments Market Size, by End User, 2017-2032 (USD Million)
TABLE 202. Middle East Brain Mapping Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 203. Middle East Brain Mapping Instruments Market Size, by Component, 2017-2032 (USD Million)
TABLE 204. Middle East Brain Mapping Instruments Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 205. Middle East Brain Mapping Instruments Market Size, by Services, 2017-2032 (USD Million)
TABLE 206. Middle East Brain Mapping Instruments Market Size, by Software, 2017-2032 (USD Million)
TABLE 207. Middle East Brain Mapping Instruments Market Size, by Technology, 2017-2032 (USD Million)
TABLE 208. Middle East Brain Mapping Instruments Market Size, by EEG, 2017-2032 (USD Million)
TABLE 209. Middle East Brain Mapping Instruments Market Size, by fMRI, 2017-2032 (USD Million)
TABLE 210. Middle East Brain Mapping Instruments Market Size, by MEG, 2017-2032 (USD Million)
TABLE 211. Middle East Brain Mapping Instruments Market Size, by NIRS, 2017-2032 (USD Million)
TABLE 212. Middle East Brain Mapping Instruments Market Size, by PET, 2017-2032 (USD Million)
TABLE 213. Middle East Brain Mapping Instruments Market Size, by Modality, 2017-2032 (USD Million)
TABLE 214. Middle East Brain Mapping Instruments Market Size, by Application, 2017-2032 (USD Million)
TABLE 215. Middle East Brain Mapping Instruments Market Size, by Clinical, 2017-2032 (USD Million)
TABLE 216. Middle East Brain Mapping Instruments Market Size, by Research, 2017-2032 (USD Million)
TABLE 217. Middle East Brain Mapping Instruments Market Size, by End User, 2017-2032 (USD Million)
TABLE 218. Africa Brain Mapping Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 219. Africa Brain Mapping Instruments Market Size, by Component, 2017-2032 (USD Million)
TABLE 220. Africa Brain Mapping Instruments Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 221. Africa Brain Mapping Instruments Market Size, by Services, 2017-2032 (USD Million)
TABLE 222. Africa Brain Mapping Instruments Market Size, by Software, 2017-2032 (USD Million)
TABLE 223. Africa Brain Mapping Instruments Market Size, by Technology, 2017-2032 (USD Million)
TABLE 224. Africa Brain Mapping Instruments Market Size, by EEG, 2017-2032 (USD Million)
TABLE 225. Africa Brain Mapping Instruments Market Size, by fMRI, 2017-2032 (USD Million)
TABLE 226. Africa Brain Mapping Instruments Market Size, by MEG, 2017-2032 (USD Million)
TABLE 227. Africa Brain Mapping Instruments Market Size, by NIRS, 2017-2032 (USD Million)
TABLE 228. Africa Brain Mapping Instruments Market Size, by PET, 2017-2032 (USD Million)
TABLE 229. Africa Brain Mapping Instruments Market Size, by Modality, 2017-2032 (USD Million)
TABLE 230. Africa Brain Mapping Instruments Market Size, by Application, 2017-2032 (USD Million)
TABLE 231. Africa Brain Mapping Instruments Market Size, by Clinical, 2017-2032 (USD Million)
TABLE 232. Africa Brain Mapping Instruments Market Size, by Research, 2017-2032 (USD Million)
TABLE 233. Africa Brain Mapping Instruments Market Size, by End User, 2017-2032 (USD Million)
TABLE 234. Global Brain Mapping Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 235. ASEAN Brain Mapping Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 236. ASEAN Brain Mapping Instruments Market Size, by Component, 2017-2032 (USD Million)
TABLE 237. ASEAN Brain Mapping Instruments Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 238. ASEAN Brain Mapping Instruments Market Size, by Services, 2017-2032 (USD Million)
TABLE 239. ASEAN Brain Mapping Instruments Market Size, by Software, 2017-2032 (USD Million)
TABLE 240. ASEAN Brain Mapping Instruments Market Size, by Technology, 2017-2032 (USD Million)
TABLE 241. ASEAN Brain Mapping Instruments Market Size, by EEG, 2017-2032 (USD Million)
TABLE 242. ASEAN Brain Mapping Instruments Market Size, by fMRI, 2017-2032 (USD Million)
TABLE 243. ASEAN Brain Mapping Instruments Market Size, by MEG, 2017-2032 (USD Million)
TABLE 244. ASEAN Brain Mapping Instruments Market Size, by NIRS, 2017-2032 (USD Million)
TABLE 245. ASEAN Brain Mapping Instruments Market Size, by PET, 2017-2032 (USD Million)
TABLE 246. ASEAN Brain Mapping Instruments Market Size, by Modality, 2017-2032 (USD Million)
TABLE 247. ASEAN Brain Mapping Instruments Market Size, by Application, 2017-2032 (USD Million)
TABLE 248. ASEAN Brain Mapping Instruments Market Size, by Clinical, 2017-2032 (USD Million)
TABLE 249. ASEAN Brain Mapping Instruments Market Size, by Research, 2017-2032 (USD Million)
TABLE 250. ASEAN Brain Mapping Instruments Market Size, by End User, 2017-2032 (USD Million)
TABLE 251. GCC Brain Mapping Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 252. GCC Brain Mapping Instruments Market Size, by Component, 2017-2032 (USD Million)
TABLE 253. GCC Brain Mapping Instruments Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 254. GCC Brain Mapping Instruments Market Size, by Services, 2017-2032 (USD Million)
TABLE 255. GCC Brain Mapping Instruments Market Size, by Software, 2017-2032 (USD Million)
TABLE 256. GCC Brain Mapping Instruments Market Size, by Technology, 2017-2032 (USD Million)
TABLE 257. GCC Brain Mapping Instruments Market Size, by EEG, 2017-2032 (USD Million)
TABLE 258. GCC Brain Mapping Instruments Market Size, by fMRI, 2017-2032 (USD Million)
TABLE 259. GCC Brain Mapping Instruments Market Size, by MEG, 2017-2032 (USD Million)
TABLE 260. GCC Brain Mapping Instruments Market Size, by NIRS, 2017-2032 (USD Million)
TABLE 261. GCC Brain Mapping Instruments Market Size, by PET, 2017-2032 (USD Million)
TABLE 262. GCC Brain Mapping Instruments Market Size, by Modality, 2017-2032 (USD Million)
TABLE 263. GCC Brain Mapping Instruments Market Size, by Application, 2017-2032 (USD Million)
TABLE 264. GCC Brain Mapping Instruments Market Size, by Clinical, 2017-2032 (USD Million)
TABLE 265. GCC Brain Mapping Instruments Market Size, by Research, 2017-2032 (USD Million)
TABLE 266. GCC Brain Mapping Instruments Market Size, by End User, 2017-2032 (USD Million)
TABLE 267. European Union Brain Mapping Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 268. European Union Brain Mapping Instruments Market Size, by Component, 2017-2032 (USD Million)
TABLE 269. European Union Brain Mapping Instruments Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 270. European Union Brain Mapping Instruments Market Size, by Services, 2017-2032 (USD Million)
TABLE 271. European Union Brain Mapping Instruments Market Size, by Software, 2017-2032 (USD Million)
TABLE 272. European Union Brain Mapping Instruments Market Size, by Technology, 2017-2032 (USD Million)
TABLE 273. European Union Brain Mapping Instruments Market Size, by EEG, 2017-2032 (USD Million)
TABLE 274. European Union Brain Mapping Instruments Market Size, by fMRI, 2017-2032 (USD Million)
TABLE 275. European Union Brain Mapping Instruments Market Size, by MEG, 2017-2032 (USD Million)
TABLE 276. European Union Brain Mapping Instruments Market Size, by NIRS, 2017-2032 (USD Million)
TABLE 277. European Union Brain Mapping Instruments Market Size, by PET, 2017-2032 (USD Million)
TABLE 278. European Union Brain Mapping Instruments Market Size, by Modality, 2017-2032 (USD Million)
TABLE 279. European Union Brain Mapping Instruments Market Size, by Application, 2017-2032 (USD Million)
TABLE 280. European Union Brain Mapping Instruments Market Size, by Clinical, 2017-2032 (USD Million)
TABLE 281. European Union Brain Mapping Instruments Market Size, by Research, 2017-2032 (USD Million)
TABLE 282. European Union Brain Mapping Instruments Market Size, by End User, 2017-2032 (USD Million)
TABLE 283. BRICS Brain Mapping Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 284. BRICS Brain Mapping Instruments Market Size, by Component, 2017-2032 (USD Million)
TABLE 285. BRICS Brain Mapping Instruments Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 286. BRICS Brain Mapping Instruments Market Size, by Services, 2017-2032 (USD Million)
TABLE 287. BRICS Brain Mapping Instruments Market Size, by Software, 2017-2032 (USD Million)
TABLE 288. BRICS Brain Mapping Instruments Market Size, by Technology, 2017-2032 (USD Million)
TABLE 289. BRICS Brain Mapping Instruments Market Size, by EEG, 2017-2032 (USD Million)
TABLE 290. BRICS Brain Mapping Instruments Market Size, by fMRI, 2017-2032 (USD Million)
TABLE 291. BRICS Brain Mapping Instruments Market Size, by MEG, 2017-2032 (USD Million)
TABLE 292. BRICS Brain Mapping Instruments Market Size, by NIRS, 2017-2032 (USD Million)
TABLE 293. BRICS Brain Mapping Instruments Market Size, by PET, 2017-2032 (USD Million)
TABLE 294. BRICS Brain Mapping Instruments Market Size, by Modality, 2017-2032 (USD Million)
TABLE 295. BRICS Brain Mapping Instruments Market Size, by Application, 2017-2032 (USD Million)
TABLE 296. BRICS Brain Mapping Instruments Market Size, by Clinical, 2017-2032 (USD Million)
TABLE 297. BRICS Brain Mapping Instruments Market Size, by Research, 2017-2032 (USD Million)
TABLE 298. BRICS Brain Mapping Instruments Market Size, by End User, 2017-2032 (USD Million)
TABLE 299. G7 Brain Mapping Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 300. G7 Brain Mapping Instruments Market Size, by Component, 2017-2032 (USD Million)
TABLE 301. G7 Brain Mapping Instruments Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 302. G7 Brain Mapping Instruments Market Size, by Services, 2017-2032 (USD Million)
TABLE 303. G7 Brain Mapping Instruments Market Size, by Software, 2017-2032 (USD Million)
TABLE 304. G7 Brain Mapping Instruments Market Size, by Technology, 2017-2032 (USD Million)
TABLE 305. G7 Brain Mapping Instruments Market Size, by EEG, 2017-2032 (USD Million)
TABLE 306. G7 Brain Mapping Instruments Market Size, by fMRI, 2017-2032 (USD Million)
TABLE 307. G7 Brain Mapping Instruments Market Size, by MEG, 2017-2032 (USD Million)
TABLE 308. G7 Brain Mapping Instruments Market Size, by NIRS, 2017-2032 (USD Million)
TABLE 309. G7 Brain Mapping Instruments Market Size, by PET, 2017-2032 (USD Million)
TABLE 310. G7 Brain Mapping Instruments Market Size, by Modality, 2017-2032 (USD Million)
TABLE 311. G7 Brain Mapping Instruments Market Size, by Application, 2017-2032 (USD Million)
TABLE 312. G7 Brain Mapping Instruments Market Size, by Clinical, 2017-2032 (USD Million)
TABLE 313. G7 Brain Mapping Instruments Market Size, by Research, 2017-2032 (USD Million)
TABLE 314. G7 Brain Mapping Instruments Market Size, by End User, 2017-2032 (USD Million)
TABLE 315. NATO Brain Mapping Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 316. NATO Brain Mapping Instruments Market Size, by Component, 2017-2032 (USD Million)
TABLE 317. NATO Brain Mapping Instruments Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 318. NATO Brain Mapping Instruments Market Size, by Services, 2017-2032 (USD Million)
TABLE 319. NATO Brain Mapping Instruments Market Size, by Software, 2017-2032 (USD Million)
TABLE 320. NATO Brain Mapping Instruments Market Size, by Technology, 2017-2032 (USD Million)
TABLE 321. NATO Brain Mapping Instruments Market Size, by EEG, 2017-2032 (USD Million)
TABLE 322. NATO Brain Mapping Instruments Market Size, by fMRI, 2017-2032 (USD Million)
TABLE 323. NATO Brain Mapping Instruments Market Size, by MEG, 2017-2032 (USD Million)
TABLE 324. NATO Brain Mapping Instruments Market Size, by NIRS, 2017-2032 (USD Million)
TABLE 325. NATO Brain Mapping Instruments Market Size, by PET, 2017-2032 (USD Million)
TABLE 326. NATO Brain Mapping Instruments Market Size, by Modality, 2017-2032 (USD Million)
TABLE 327. NATO Brain Mapping Instruments Market Size, by Application, 2017-2032 (USD Million)
TABLE 328. NATO Brain Mapping Instruments Market Size, by Clinical, 2017-2032 (USD Million)
TABLE 329. NATO Brain Mapping Instruments Market Size, by Research, 2017-2032 (USD Million)
TABLE 330. NATO Brain Mapping Instruments Market Size, by End User, 2017-2032 (USD Million)
TABLE 331. Global Brain Mapping Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 332. United States Brain Mapping Instruments Market Size, 2017-2032 (USD Million)
TABLE 333. United States Brain Mapping Instruments Market Size, by Component, 2017-2032 (USD Million)
TABLE 334. United States Brain Mapping Instruments Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 335. United States Brain Mapping Instruments Market Size, by Services, 2017-2032 (USD Million)
TABLE 336. United States Brain Mapping Instruments Market Size, by Software, 2017-2032 (USD Million)
TABLE 337. United States Brain Mapping Instruments Market Size, by Technology, 2017-2032 (USD Million)
TABLE 338. United States Brain Mapping Instruments Market Size, by EEG, 2017-2032 (USD Million)
TABLE 339. United States Brain Mapping Instruments Market Size, by fMRI, 2017-2032 (USD Million)
TABLE 340. United States Brain Mapping Instruments Market Size, by MEG, 2017-2032 (USD Million)
TABLE 341. United States Brain Mapping Instruments Market Size, by NIRS, 2017-2032 (USD Million)
TABLE 342. United States Brain Mapping Instruments Market Size, by PET, 2017-2032 (USD Million)
TABLE 343. United States Brain Mapping Instruments Market Size, by Modality, 2017-2032 (USD Million)
TABLE 344. United States Brain Mapping Instruments Market Size, by Application, 2017-2032 (USD Million)
TABLE 345. United States Brain Mapping Instruments Market Size, by Clinical, 2017-2032 (USD Million)
TABLE 346. United States Brain Mapping Instruments Market Size, by Research, 2017-2032 (USD Million)
TABLE 347. United States Brain Mapping Instruments Market Size, by End User, 2017-2032 (USD Million)
TABLE 348. Canada Brain Mapping Instruments Market Size, 2017-2032 (USD Million)
TABLE 349. Canada Brain Mapping Instruments Market Size, by Component, 2017-2032 (USD Million)
TABLE 350. Canada Brain Mapping Instruments Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 351. Canada Brain Mapping Instruments Market Size, by Services, 2017-2032 (USD Million)
TABLE 352. Canada Brain Mapping Instruments Market Size, by Software, 2017-2032 (USD Million)
TABLE 353. Canada Brain Mapping Instruments Market Size, by Technology, 2017-2032 (USD Million)
TABLE 354. Canada Brain Mapping Instruments Market Size, by EEG, 2017-2032 (USD Million)
TABLE 355. Canada Brain Mapping Instruments Market Size, by fMRI, 2017-2032 (USD Million)
TABLE 356. Canada Brain Mapping Instruments Market Size, by MEG, 2017-2032 (USD Million)
TABLE 357. Canada Brain Mapping Instruments Market Size, by NIRS, 2017-2032 (USD Million)
TABLE 358. Canada Brain Mapping Instruments Market Size, by PET, 2017-2032 (USD Million)
TABLE 359. Canada Brain Mapping Instruments Market Size, by Modality, 2017-2032 (USD Million)
TABLE 360. Canada Brain Mapping Instruments Market Size, by Application, 2017-2032 (USD Million)
TABLE 361. Canada Brain Mapping Instruments Market Size, by Clinical, 2017-2032 (USD Million)
TABLE 362. Canada Brain Mapping Instruments Market Size, by Research, 2017-2032 (USD Million)
TABLE 363. Canada Brain Mapping Instruments Market Size, by End User, 2017-2032 (USD Million)
TABLE 364. Mexico Brain Mapping Instruments Market Size, 2017-2032 (USD Million)
TABLE 365. Mexico Brain Mapping Instruments Market Size, by Component, 2017-2032 (USD Million)

Companies Mentioned

  • Abbott Laboratories
  • Advanced Brain Monitoring, Inc.
  • ANT Neuro B.V.
  • Boston Scientific Corporation
  • Brain Products GmbH
  • Cadwell Industries, Inc.
  • CGX, A Cognionics Company
  • Compumedics Limited
  • Deymed Diagnostic
  • Elekta AB
  • General Electric Company
  • Koninklijke Philips N.V.
  • Magstim Company Limited
  • Medtronic plc
  • MEGIN Oy
  • Mrisym AG
  • Natus Medical Incorporated
  • Neuroelectrics Barcelona SL
  • Neurosoft LLC
  • NeuroWave Systems Inc.
  • Nihon Kohden Corporation
  • Rogue Research Inc.
  • Siemens Healthineers AG
  • York Instruments Ltd.

Table Information

Report AttributeDetails
No. of Pages183
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 2.31 Billion
Forecasted Market Value ( USD ) by 2032 $ 5.15 Billion
Compound Annual Growth Rate14.3%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Brain Mapping Instruments - Global Strategic Business Report - Product Image

Brain Mapping Instruments - Global Strategic Business Report

  • Report
  • 185 Pages
  • Global
From
Brain Mapping Instruments Market Report 2026 - Product Image

Brain Mapping Instruments Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Neurofeedback System Market - Global Forecast 2026-2032 - Product Image

Neurofeedback System Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Brain-Computer Interface Market - Global Forecast 2026-2032 - Product Image

Brain-Computer Interface Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
ECoG Electrode Market Report: Trends, Forecast and Competitive Analysis to 2035 - Product Image

ECoG Electrode Market Report: Trends, Forecast and Competitive Analysis to 2035

  • Report
  • 181 Pages
  • Global
From

About the Brain Mapping Market

Brain Mapping is a technology used in neurology devices to measure and map the electrical activity of the brain. It is used to diagnose and treat neurological disorders such as epilepsy, Parkinson's disease, and Alzheimer's disease. Brain mapping is also used to study the effects of drugs, brain injuries, and other neurological conditions. It is used to measure brain activity in order to better understand the brain's functioning and to develop treatments for neurological disorders. Brain mapping technology is used in a variety of neurology devices, including electroencephalography (EEG) machines, functional magnetic resonance imaging (fMRI) machines, and magnetoencephalography (MEG) machines. EEG machines measure electrical activity in the brain, while fMRI and MEG machines measure changes in the brain's magnetic field. Brain mapping technology is used by a variety of companies, including NeuroPace, NeuroSky, BrainScope, and NeuroVista. These companies specialize in the development of neurology devices and technologies for the diagnosis and treatment of neurological disorders. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.